Atrás
Rango del Día
$18.60
$20.16
Rango de 52 Semanas
$10.01
$24.33
Volumen
224,125
Promedio 50D / 200D
$20.20
/
$16.40
Cierre Anterior
$18.92
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (631 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -13.2 | 0.2 |
| P/B | 4.6 | 3.0 |
| ROE % | -30.8 | 3.6 |
| Net Margin % | -60.0 | 3.8 |
| Rev Growth 5Y % | — | 9.9 |
| D/E | 0.1 | 0.2 |
Precio Objetivo de Analistas
Hold
$30.00
+59.8%
EPS Futuro
-$1.46
Ingresos Est.
113.14M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2028 |
-$0.86
-$1.03 – -$0.76
|
184.69M | 3 |
| FY2027 |
-$1.01
-$1.41 – -$0.69
|
144.59M | 7 |
| FY2026 |
-$1.46
-$1.63 – -$1.35
|
113.14M | 7 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-24 | -$0.41 | -$0.36 | +12.6% |
| 2025-11-04 | -$0.43 | -$0.37 | +14.0% |
| 2025-08-05 | -$0.40 | -$0.38 | +5.0% |
| 2025-05-08 | -$0.43 | -$0.36 | +16.3% |
| 2025-02-25 | -$0.32 | -$0.40 | -25.0% |
| 2024-11-12 | -$0.82 | -$1.85 | -125.6% |
| 2024-10-11 | N/A | -$1.59 | — |
| 2024-03-31 | N/A | -$1.59 | — |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Puntos Clave
Debt/Equity of 0.14 — conservative balance sheet
Negative free cash flow of -41.58M
PEG of 0.26 suggests growth is underpriced
Capital efficient — spends only 0.86% of revenue on capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)36.09%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-30.83%
ROIC-24.66%
Net Margin-59.97%
Op. Margin-65.57%
Seguridad
Debt / Equity
0.14
Current Ratio9.73
Interest Coverage-30.90
Valoración
P/E Ratio
-13.23
Forward P/EN/A
P/B Ratio4.55
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 36.09% | Revenue Growth (3Y) | 40.33% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 89.06M | Net Income (TTM) | -53.41M |
| ROE | -30.83% | ROA | -27.28% |
| Gross Margin | 87.89% | Operating Margin | -65.57% |
| Net Margin | -59.97% | Free Cash Flow (TTM) | -41.58M |
| ROIC | -24.66% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.14 | Current Ratio | 9.73 |
| Interest Coverage | -30.90 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -13.23 | Forward P/E | N/A |
| P/B Ratio | 4.55 | P/S Ratio | 7.93 |
| PEG Ratio | 0.26 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | 6.24 | Fwd Earnings Yield | N/A |
| FCF Yield | -5.88% | ||
| Market Cap | 706.53M | Enterprise Value | 688.33M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 89.06M | 65.44M | 45.23M | 25.92M |
| Net Income | -53.41M | -40.46M | -29.46M | -37.16M |
| EPS (Diluted) | -1.46 | -3.39 | -1.26 | -1.59 |
| Gross Profit | 78.27M | 56.75M | 38.16M | 21.49M |
| Operating Income | -58.40M | -39.71M | -30.04M | -36.02M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 195.80M | 225.41M | 58.92M | 86.46M |
| Total Liabilities | 40.47M | 34.25M | 171.17M | 172.86M |
| Shareholders' Equity | 155.34M | 191.17M | -112.25M | -86.40M |
| Total Debt | 22.28M | 21.96M | 14.20M | 18.22M |
| Cash & Equivalents | 40.48M | 194.37M | 34.50M | 68.24M |
| Current Assets | 186.72M | 217.27M | 51.96M | 79.80M |
| Current Liabilities | 19.19M | 12.99M | 21.60M | 9.86M |